Many vascular diseases are closely related to inflammatory processes, where activation of the transcription factor nuclear factor-kappa B (NF-kB) plays a pivotal role by augmenting the expression of various genes such as cytokines, chemokines, leukocyte-adhesion molecules.
Xanthoangelol D Isolated from the Roots of Angelica keiskei Inhibits Endothelin-1 Production through the Suppression of Nuclear Factor-k kB
gelatin-coated Petri dishes or plate in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal calf serum, 100 U/ml of penicillin, and 100 mg/ml streptomycin at 37°C in a humidified atmosphere of 95% air and 5% CO 2 as described. 20) For all experiments, PAECs were grown to confluence then made quiescent by incubation with serum-free DMEM containing 0.01% heat-inactivated bovine serum albumin for 12 h. All cultured PAECs were used from passages 5 to 10.
Preparation of Nuclear Extracts and Electrophoretic Mobility Shift Assay (EMSA) Nuclear extracts were prepared from PAECs using the method of Schreiber et al. 21) The nuclear extracts (2 mg protein) were used for EMSA. Double-stranded oligonucleotides containing the most common NF-kB consensus binding site 5Ј-AGT TGA GGG GAC TTT CCC AGG C-3Ј or Oct-1 consensus binding site 5Ј-TGT CGA ATG CAA ATC ACT AGA A-3Ј were end-labeled with [g-32 P]ATP, using T4 polynucleotide kinase. DNA-protein complexes were resolved on 6% nondenaturing polyacrylamide gels. After electrophoresis, gels were dried and exposed to imaging plates (Fuji Film, Tokyo, Japan) at room temperature. The protein-DNA complexes were visualized using autoradiography.
Western Blot Analysis All procedures were performed, according to the method described elsewhere. 20) Total protein (25 mg) was separated on a 12% SDS-polyacrylamide gel. After transfer to nitrocellulose membranes (Amersham Biosciences Corp., Piscataway, NJ, U.S.A.), the membranes were incubated overnight with rabbit antibody for human IkBa (Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.) at room temperature or rabbit polyclonal antibody for human phospho-IkBa (Ser32) (New England Biolabs, Beverly, MA, U.S.A.) at 4°C. Membranes were washed and incubated with goat anti-rabbit horseradish peroxidase-linked immunoglobulin G (Zymed Laboratories, South San Fransisco, CA, U.S.A.). Antibody-labeled proteins were detected by enhanced chemiluminescence Western blotting kits (Amersham Biosciences Corp., Piscataway, NJ, U.S.A.).
Northern Blot Analysis For Northern blot analysis, the isolated total RNA (5 mg per lane) was subjected to electrophoresis on a 1.1% agarose gel containing formaldehyde and transferred to Hybond-XL membrane (Amersham Biosciences Corp., Piscataway, NJ, U.S.A.). This membrane was prehybridized for 1 h at 68°C in PerfectHyb hybridization solution (TOYOBO, Osaka, Japan) and then hybridized with porcine prepro ET-1 cDNA probe (a gift from Dr. K. Goto, University of Tsukuba) and glyceraldehydes 3-phosphate dehydrogenase (GAPDH) cDNA probe (Clontech, Palo Alto, CA, U.S.A.) labeled with [a-32 P]dCTP, using Random Primer DNA Labeling Kit (Takara Shuzo, Kyoto, Japan). After hybridization, the membrane was washed and then exposed to imaging plates. Autoradiograms of ET-1 were quantified by densitometric analyses, and signals of ET-1 mRNA were normalized for each sample, with respect to density of the corresponding signal for GAPDH mRNA.
Statistics Analysis All values are expressed as meanϮ S.E.M. For statistical analysis, we used one-way analysis of variance followed by Bonferroni's multiple comparison tests. Difference were considered statistically significant at pϽ0.05.
RESULTS

Effects of Xanthoangelol D, E, F and Xanthoangelol on Basal and TNF-a a Induced NF-k kB Activation in PAECs
We examined the effect of each xanthoangelol on basal and TNF-a-induced NF-kB activation in PAECs. As shown in Fig. 2 (left panel), xanthoangelol E, F and xanthoangelol had no effects on both basal and TNF-a-stimulated conditions. On the other hand, when PAECs were treated with xanthoangelol D, TNF-a-induced NF-kB activation was completely suppressed. Although the changes in NF-kB activation in basal conditions were not easily viewable, the suppressive effect of xanthoangelol D on basal NF-kB activation was detectable when gels were exposed to imaging plates for longer period (Fig. 2, right panel) . Xanthoangelol D produced doserelated inhibitions in TNF-a-induced NF-kB activation (Fig.  3, upper panel) , but xanthoangelol did not have any inhibitory effects on Oct-1, which is a ubiquitous transcriptional factor, in basal and TNF-a-stimulated conditions (Fig.  3, lower panel) .
Effects of Xanthoangelol D on Ik kBa a Phosphorylation and Degradation in PAECs To clarify which steps of NFkB activation is inhibited by xanthoangelol D, we investigated the effects of this compound on IkBa phosphorylation and degradation using Western blot analysis. As shown in Fig. 4 , IkBa protein expression began to decrease at 3 min after TNF-a addition, and completely disappeared at 10 min, and then increased gradually. In the case of phosphorylated IkBa protein, the amount of protein rapidly increased at 3 min after TNF-a addition and disappeared at 15 min. Thereafter, the phosphorylated IkBa protein began to increase again, as well as did IkBa. The treatment with xan- 
Inhibitory Effect of Xanthoangelol on ET-1 Gene Expression in PAECs
It is well known that NF-kB regulates various gene expressions including cytokines and adhesion molecules in vascular endothelial cells. 2) We and others have demonstrated that ET-1 gene expression in endothelial cells is also under the control of NF-kB. [10] [11] [12] Thus, we examined the effects of xanthoangelol D on prepro ET-1 mRNA expression in PAECs. As shown in Fig. 5 , xanthoangelol D markedly inhibited basal prepro ET-1 mRNA expression in PAECs. Although TNF-a enhanced prepro ET-1 mRNA expression in a time-dependent manner, xanthoangelol D significantly suppressed this enhancement.
DISCUSSION
There is accumulating evidence indicating that chalcones such as 2Ј-hydroxychalcone and broussochalcone inhibit cytokine-induced adhesion molecule and inducible nitric oxide synthase gene expressions in macrophages and endothelial cells through the suppression of NF-kB activation. [22] [23] [24] Thus, in the present study, we examined the effects of four chalcones extracted from the roots of Angelica keiskei KOIDZUMI on NF-kB activation. Our results revealed that xanthoangelol D but not xanthoangelol, xanthoangelol E and F had a potent suppressive action on basal and TNF-a-induced NF-kB activation in PAECs. These findings indicate that xanthoangelol D is a useful tool for clarifying physiological and pathophysiological roles of NF-kB.
It has been shown that an increase in the cellular production of ROS serve as messengers mediating the cytokine-induced NF-kB activation in various cell types, based on the findings that many antioxidants are capable of effectively blocking NF-kB activation through the stabilization of NFkB/IkB complex. [25] [26] [27] It has been also reported that ROS play an important role in the step of IkBa phosphorylation. 28) Furthermore, recent studies have demonstrated that many chalcones possess antioxidative activities. [22] [23] [24] Taken together, one can speculate that chalcones have an inhibitory effect on the phosphorylation of IkBa by trapping ROS. In the present study, we found that xanthoangel D remarkably reduced the activation of NF-kB under basal and TNF-astimulated conditions. Moreover, we demonstrated that these inhibitory effects resulted from the suppression of IkBa phosphorylation. Therefore, it is likely that xanthoangelol Dinduced inhibitions of IkBa phospholylation and NF-kB activation are related, at least partly, to its antioxidant property. On the other hand, although the reason why other chalcones except xanthoangelol D failed to attenuate the NF-kB activation in basal and TNF-a-stimulated conditions remains unclear, these different efficacies may be possibly due to an antioxidative activity in each compound. Further studies are required to determine differences of antioxidative activities of xanthoangelols.
In contrast to the above facts, Hayakawa et al. 29) has recently demonstrated that NF-kB inhibition by antioxidants such as N-acetyl-L-cysteine (NAC) and pyrrolidine dithiocarbamate (PDTC) is independent of their antioxidative function. They revealed that NAC suppressed TNF-a-stimulated NF-kB activation by reducing the affinity of receptor to TNF. On the other hand, PDTC inhibits NF-kB activation through the decreases in IkB-ubiquitin ligase activity. Thus, further studies are required to clarify how much antioxidative function of xanthoangelol D is involved in the inhibitory effects on TNF-a-stimulated NF-kB activation and whether xanthoangelol D inhibits the other step of NF-kB activation system.
ET-1 is a potent vasoconstrictor peptide and possesses a number of biological activities leading to vascular disorders. 5, 6) Several studies have indicated that ET-1 gene is regulated by a variety of transcriptional factors such as activator protein-1, GATA-2, and nuclear factor-1. 6, 30) We and others have recently demonstrated that NF-kB is also responsible for the regulation of ET-1 gene expression in vascular endothelial cells. This view is based on findings that various NF-kB suppressors such as proteasome inhibitors, antioxidants, and an IkBa phosphorylation inhibitor can decrease the ET-1 production in PAECs. 11, 12) Moreover, the kB site, a binding sequence for the activated NF-kB, is known to locate in the promoter region of human ET-1 gene. 10) In the present study, we showed that xanthoangelol D remarkably reduced basal and TNF-a-induced prepro ET-1 mRNA expression in PAECs. We also observed that these suppressive effects of xanthoangelol D were accompanied by a decrease in ET-1 release from PAECs under basal and TNF-a-stimulated conditions (data not shown). Thus, it is reasonable to consider that In conclusion, our results clearly indicate that xanthoangelol D suppresses basal and TNF-a-induced ET-1 production, by inhibiting the activation of NF-kB. Moreover, it appears that xanthoangelol D has a beneficial effect on ET-1-mediated vascular diseases.
